We have recently shown that analysis of BAT-26, was sucient to establish the Replication Error status of colorectal tumors and cell lines without the need for matching normal DNA. BAT-26, a poly(A) tract in the 5th intron of the hMSH2 gene, does not present signi®cant size variation either between the allleles of one individual or between alleles of dierent individuals. In colorectal tumors without defects in the replication error system (RER7 phenotype), BAT-26 is also quasimonomorphic. On the contrary, in RER+ colorectal tumors, BAT-26 shows unstable shortened alleles. In order to see whether this behaviour was speci®c for BAT-26, or was a more general phenomenon for mononucleotide repeat microsatellites, we analysed eight other mononucleotide repeats. In control individuals (72 samples) and in RER7 colorectal tumors and cell lines (55 samples), these microsatellites were polymorphic, dimorphic, quasi-monomorphic or monomorphic, indicating that the quasi-monomorphic nature of BAT-26 was not a general rule. All of them showed a tendency to be shorter in RER+ colorectal tumors and cell lines (19 samples), but only quasi-monomorphic and monomorphic mononucleotide repeats could be used to determine the RER status of tumors without matching normal DNA, although with a lower eciency than BAT-26 due to either a smaller range of shortening in RER+ tumors or to a larger number of false negative cases.
Introduction
Microsatellites are normal regions of the genome and are composed of one to six bases of repeated DNA sequences. They are known to be highly polymorphic and are widely used for studies on losses of heterozygosity and linkage analysis. More recently, their study has shown a new type of genetic alteration termed microsatellite instability characteristic of tumors showing unrepaired replication errors (RER phenotype). This phenotype was ®rst described in colorectal tumors of Hereditary Non-Polyposis Colorectal Cancer (HNPCC) and sporadic patients Thibodeau et al., 1993; Ionov et al., 1993) , and then in extracolonic sporadic tumors belonging to the HNPCC spectrum . The RER phenotype has also been described in tumors not belonging to the HNPCC spectrum (reviewed by Eshleman and Markowitz, 1995) , but in these cases, results are more con¯icting. This is due to the absence of a consensus to de®ne RER+ tumors since there is a large discrepancy concerning the number of microsatellite loci examined, and the threshold percentage of unstable loci required to classify a tumor as RER+. We have recently proposed that BAT-26, a poly(A) tract localized in the 5th exon of hMSH2, could be used to establish the RER status of colorectal tumors without the need of matching normal DNA (Hoang et al., 1997) . We have shown that this mononucleotide repeat microsatellite did not show signi®cant size variation between both alleles, or between individuals in DNA from normal tissues and RER7 tumors and cell lines, and was quasi-monomorphic. On the other hand, BAT-26 showed shortened alleles in sporadic colorectal RER+ tumors and cell lines (Hoang et al., 1997) . Such allelic properties are dierent from that which are observed for dinucleotide repeat microsatellites which are generally highly polymorphic and the sizes of which are not altered in all RER+ tumor samples. In order to determine whether this phenomenon was speci®c for BAT-26, or a more general dierence between mono and dinucleotide repeat microsatellites, we analysed eight other mononucleotide repeat microsatellites and compared their allelic characteristics with those of BAT-26.
Results
Each mononucleotide repeat microsatellite was analysed for 72 independant CEPH family members as control (Figure 1 ). In each case, allele sizes were measured as compared to the most frequent allele quoted as 0, and size dierences are reported in Figure  2 . BAT-13, BAT-RII and IGFRII-R4 were monomorphic without any allelic size variation. BAT-26, BAT-25, BAT-34C4 and BAT-16 were quasi-monomormorphic with allelic size variation not exceeding 2 nucleotides and with one major allele for BAT-26, two for BAT-25 and BAT-34C4, and three for BAT-16. Due to the small allelic size dierences in these markers and to Taq polymerase stammering during PCR reaction, it was dicult to determine whether DNA was homozygous or heterozygous for the dierent alleles, and we only measured the size of the larger ones. BAT-21 was dimorphic with an 8-nucleotide size dierence between the two alleles and few samples showing small size dierences as compared to these two major alleles. BAT-40 was polymorphic with a percentage of heterozygosity of 72%. Allelic size variation was from 716 to +3 nucleotides as compared to the most frequent allele. For BAT-21 and BAT-40, sizes of both alleles were measured and are reported in Figure 2 .
The same mononucleotide repeat microsatellites were analysed for 48 RER7and RER+ primary tumors ( Figure 3 ) and 26 cell lines (data not shown). Allelic sizes in RER7 primary tumors and cell lines were measured for each microsatellite as described above and are reported in Figure 2 . All RER7 samples showed the same range of allelic size variations as that in control individuals: monomorphic for BAT-13, BAT-RII and IGFRII-R4, quasimonomorphic for BAT-26, BAT-25, BAT-34C4 and BAT-16, dimorphic for BAT-21 and polymorphic for BAT-40. The only exception was one RER7 cell line, LS1034, showing a 1 bp longer product for BAT-RII.
The majority of the 19 analysed RER+ tumors and cell lines showed for BAT-26, BAT-25, BAT-34C4, BAT-16, BAT-13 and BAT-RII, in addition to alleles probably due to contaminating normal cells, alleles with reduced size as compared to the ones observed in DNA from control individuals and from RER7 tumors (Table 1) . When two additional alleles were present, we only reported in Figure 2 and Table 1 the size of the one showing the larger dierence. In decreasing order of size variation, shortening was from 16 to 6 bp for BAT-26, 10 to 4 bp for BAT-25, 7 to 2 bp for BAT-16, 5 to 3 bp for BAT-34C4, 3 to 1 bp for BAT-13 and 2 to 1 bp for BAT-RII. Moreover, an insertion of 3 bp for BAT-34C4 and 2 bp for BAT-13 was observed in one tumor each, and a 1 bp insertion for BAT-RII was seen in two tumors. These insertions were also outside the range of allelic sizes in normal DNA for the corresponding monucleotide repeats. Two dierent RER+ cell lines did not show size variation as compared to normal DNA for BAT-13 and BAT-34C4 respectively.
Out of the 18 RER+ samples analysed for IGFRII-R4, two had a 1 bp deletion, and three presented a 1 bp insertion. The remaining 13 samples were not dierent from the DNA controls.
The majority of RER+ samples showed BAT-21 alleles with a size dierent from the biallelic pro®le observed in control and RER-tumor DNA. BAT-40 was also highly polymorphic in RER+ tumors and cell lines, but allelic size variation was from 729 to 73 nucleotides as compared to the allele quoted 0 in control DNA (in Figure 2 , alleles showing a deletion equal or superior to 16 nucleotides were grouped in the same column for BAT-40). The average allelic size of BAT-40 was thus smaller in RER+ tumors than in RER7 tumors and control DNA but both pro®les overlap.
Discussion
Of the nine mononucleotide repeat microsatellites analysed in this study, one, BAT-40 was polymorphic with a large number of dierent alleles and behaved like most of the dinucleotide microsatellites. Polymorphism of BAT-21 was limited to two alleles presenting a signi®cant size dierence. The seven other mononucleotide repeat microsatellites were either monomorphic or quasi-monomorphic in control individuals from CEPH families and in RER7 tumors and cell lines. Other mononucleotide repeats such as Figure 3 Allelic pro®les of mononucleotide repeat microsatellites in representative primary colorectal tumors. RER+ tumors are indicated by black dots 50C10, a poly(A) run 3' to a repetitive Alu sequence contained in a transcript overexpressed in tumors, has also been shown to be non-polymorphic in normal DNA (Chen et al., 1995) .
The absence of polymorphism for these mononucleotide runs may suggest a function which would be impaired by important size variation. In the present study, BAT-RII and IGFRII are the only mononucleotide repeat microsatellites in coding sequences since they are localized in exons of the TGF b receptor type II gene Parsons et al., 1995) and Insulin-like growth factor receptor type II gene respectively (Souza et al., 1996) . Any deletion or insertion of one or two nucleotides in these mononucleotide runs would alter the open reading frame, and it is thus not surprising that there is a selective pressure against size variation of these repeats. BAT-13 is a 13T run, BAT-16 a 16T run and BAT-21 a 21T run (following a TA repeat) in the polypyrimidine tracts upstream of the AG consensus sequence of the splice acceptor sites in intron 1 of the hMSH2 gene (Liu et al., 1994) , intron 6 of the hPMS2 gene and intron 11 of the hMLH1 gene (Kolodner et al., 1995) respectively. BAT-26 is a 26 A run just downstream of the consensus sequence of the splice donor site of intron 5 of the hMSH2 gene (Liu et al., 1994) . These sequences may have a role in regulating mRNA processing, but this has not been exprimentally demonstrated. BAT-34C4 is located in the 3' untranslated part of p53 mRNA (Lamb and Crawford, 1986) with an unknown role, if any. BAT-25 and BAT-40 are in intron 16 of the c-kit oncogene and in the second intron of the 3-b-hydroxysteroid dehydrogenase gene respectively in regions with no particular known role for splicing regulation
In RER+ tumors and cell lines, the above described mononucleotide repeat microsatellites showed evident size variation as compared to`normal alleles' in 100% of the cases for BAT-26, BAT-25, BAT-16 and BAT-RII, in 95% of the cases for BAT-34C4 and BAT-13 and in 25% of the cases for IGFRII-R4. Size alterations have already been described for BAT-26, BAT-25 and BAT-13 in RER+ colorectal cell lines , but it was not reported that the analysis of normal matching DNA was not necessary to observe such an instability. Shortening of 50C10 was also shown to occur in a small series of proximal colorectal tumors not characterized for their RER status (Chen et al., 1995) .
Size variations in BAT-RII Parsons et al., 1995) and IGFRII-R4 (Souza et al., 1996) as well as in three 8-mononucleotide runs localized in the coding sequences of the hMSH3, hMSH6 (GTBP) (Malhosyan et al., 1996) and BAX genes (Rampino et al., 1997) have been observed in dierent subsets of primary RER+ tumors. All these frameshift mutations may have direct consequences in the progression of RER+ tumors, but the prevalence of the mutations of each gene and their relationship are not yet completely known. In our series of RER+ colorectal samples, we did not observe an anticorrespondance for alterations in BAT-RII and IGFRII-R4 such as that previously reported (Souza et al., 1996) . Whether the very frequent size alterations in RER+ tumors of the mononucleotide repeat microsatellites localized close to consensus splice sequences (BAT-26, BAT-21, BAT-16 and BAT-13) is a consequence of the general phenomenon of microsatellite instability, or may have a role in tumoral progression remains to be determined.
We observed in the present study that the larger the mononucleotide repeat was, the greater was the range of size variation in RER+ samples although this dierence was not completely proportional since, for example, BAT-26 and BAT-25 which have almost the same size showed a great dierence in their variability (716 to 710 bp of maximum shortening for BAT-26 abd BAT-25 respectively). Moreover, the presence of an imperfect correlation between the amplitudes of size nd: not done. (a) The LoVo cell line is known to be homozygously deleted for exons 4 ± 8 of the hMSH2 gene , and thus does not amplify The HCT15 cell line is mutated on the GTBP gene and unstable on mononucleotide repeat microsatellites, but stable on dinucleotide repeat microsatellites alterations of the dierent mononucleotide repeats in the same RER+ DNA sample calls for further studies in order to determine whether the analysis of these repeats could be used as a molecular clock to follow tumoral progression in tumors with replication errors.
The present study showed that BAT-26 was the best mononucleotide repeat microsatellite to establish the RER status of 74 colorectal primary tumors and cell lines without matching normal DNA since it was unstable in 100% of tested RER+ samples and showed a large size variation. We have already shown in a larger series of tumors that BAT-26, was able to con®rm the RER status of 159 out of 160 colorectal tumors and cell lines (Hoang et al., 1997) . We have now extended this analysis to a series of more than 500 human tumors of various tissues already characterized for their RER status, and observed that false positive cases represented only 0.5% of the analysed samples (Zhou et al., submitted) . In some cases however, RER7 and RER+ tumors showed intermediate BAT-26 allelic size variations signi®cant enough to attract attention, but too small to unambiguously determine their RER status. In those particular cases, the use of other mononucleotide repeat microsatellites was necessary to resolve the ambiguity. The present work indicates that BAT-25 and BAT-34C4 are the most useful among the tested loci.
Materials and methods

Patients
DNA was extracted using standard methods from lymphoblasts of 72 unrelated healthy family members from the Centre d'Etude pour le Polymorphisme Humain (CEPH), from 48 colorectal tumors from patients undergoing surgery in our institution and from matching normal DNA. As far as we know, none of the patients included in this series had a family history suggestive of Hereditary Non-Polyposis Colorectal Cancer (HNPCC). The RER status of tumors was established by the comparative analysis of an average of 65 poly(CA) microsatellites in tumor and matching normal DNA. Eleven tumors showed microsatellite instability on more than 50% of the analysed loci and were classi®ed as RER+. The other tumors had an instability index below 6% and were considered as RER7 (Hoang et al., 1997) .
The determination of the RER status of 23 colorectal cell lines has already been described (Cottu et al., 1996) . Three additional cell lines were included in this study, two established in the laboratory from primary RER+ tumors (LefrancË ois et al., 1989) and SW48 described as RER+ by other authors . Taken together, we analysed 18 RER7 and seven RER+ (HCT116, LoVo, LS174T, Co115, TC7, TC71 and SW48) cell lines. The last cell line was HCT15 which is RER7 when analysed with dinucleotide repeats, but which is unstable on mononucleotide repeat microsatellites due to a mutation on the GTBP gene .
Mononucleotide repeat microsatellites analysis
Primers used to amplify BAT-26, BAT-25, BAT-40, BAT-13 and BAT-RII and PCR conditions were as described . IGFRII was ampli®ed using primer set R4 as described (Souza et al., 1996) . The primers for BAT-34C4 were 5'-ACCCTGGAGGATTTCATCTC-3' and 5'-AACAAAGCGAGACCCAGTCT-3'; for BAT-21, 5'-ATACTTCTTATTCTGAGTCT-3' and 5'-ATTTAAC-CATCTCCCCAGAG -3'; for BAT-16 5'-TCCACTG TGTCTTTATTAGG -3' and 5' -AAACCGTACTCTTCA-CACAC-3'. PCR ampli®cation was performed with primers at 300 nM each with 1.5 mM MgCl 2 , 100 mM deoxynucleotide triphosphate, 0.25 units of Taq polymerase and 50 ng of DNA in a total volume of 20 ml. PCR conditions were 958C for 5 min followed by 35 cycles (958C for 30 s, 608C for BAT-34C4, 568C for BAT-16 and 528C for BAT-21 for 1 min, and 708C for 1 min), and a ®nal elongation at 708C for 10 min. All PCR products were separated on 5.6 M urea/32% formamide/7% polyacrylamide gels, transferred overnight onto Hybond N + nylon membranes (Amersham) and hybridized with a 32 P-labeled probe made with one of the primers used in the corresponding PCR reaction.
BAT-13, BAT-26, BAT-16 and BAT-21 are within introns 1 and 5 of the hMSH2 gene, intron 6 of the hPMS2 gene and intron 11 of the hMLH1 gene respectively. BAT-25 and BAT-40 are in introns of the c-kit oncogene and the 3-bhydroxysteroid dehydrogenase gene respectively. BAT-RII contains a stretch of 10 A residues in the coding sequence of the TGFb type II receptor gene. The PCR product of the R4 locus contains an 8-deoxyguanine repeat in the coding sequence of the IGFRII gene. BAT-34C4 contains a (T) 3 C(T) 6 C(T) 17 C(T) 5 C(T) 3 sequence in the 3' non-translated part of the 11th exon of p53.
